STOCK TITAN

Cue Health Inc. - HLTH STOCK NEWS

Welcome to our dedicated page for Cue Health news (Ticker: HLTH), a resource for investors and traders seeking the latest updates and insights on Cue Health stock.

Cue Health Inc. (HLTH) delivers innovative at-home diagnostic solutions through its integrated platform of molecular testing and mobile health technology. This news hub provides investors and stakeholders with essential updates about the company’s financial performance, product developments, and strategic initiatives.

Access timely announcements including quarterly earnings reports, FDA clearances, partnership agreements, and research breakthroughs. Our curated collection ensures you stay informed about HLTH’s advancements in digital health diagnostics without speculative commentary.

Key updates cover regulatory milestones, new test kit approvals, executive leadership changes, and scientific validation studies. Each release maintains focus on verifiable facts about the company’s patented technology and market position.

Bookmark this page for direct access to primary source materials about Cue Health’s progress in transforming personal health monitoring. Check regularly for objective updates on their mobile-integrated diagnostic ecosystem and business developments.

Rhea-AI Summary
Cue Health stockholders call for Board to cut expenditures and focus on core business
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
none
-
Rhea-AI Summary
Cue Health's molecular COVID-19 test demonstrated 99.4% accuracy compared to lab-based PCR in a clinical study on asymptomatic people. The test provides fast results in 20 minutes and has 100% clinical sensitivity to detect positive cases. The study also showed high test sensitivity (98.7%) for detection at varying stages of infection and viral load. Cue's test offers critical benefits such as reducing the likelihood of spread, facilitating earlier access to treatment, and maintaining cost-effectiveness. Cue recently received FDA approval for its COVID-19 test.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.43%
Tags
covid-19
-
Rhea-AI Summary
Cue Health adopts shareholder rights plan to protect long-term value, responding to significant third-party share accumulation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.38%
Tags
none
Rhea-AI Summary
Tarsadia Investments calls on Cue Health board to take immediate action to prevent further destruction of stockholder value. They criticize Cue's flawed capital allocation and unsustainable cost structure. Urgent change is needed to address declining cash balance and destruction of stockholder value. Cue's stockholders have experienced a -97% decline in share price from IPO. Quarterly product revenues declined -97% from $223 million in Q3 2021 to $8 million in the past quarter. Cue may run out of cash and be required to raise $75 million in new equity, resulting in over 50% dilution to existing shareholders. Tarsadia submits Section 220 request to inspect company's books and records.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.45%
Tags
none
-
Rhea-AI Summary
Cue Health to present at investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.46%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
Rhea-AI Summary
Cue Health awarded $28 million contract to develop multiplex test for flu, RSV, and COVID-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.6%
Tags
covid-19
-
Rhea-AI Summary
Cue Health Inc. (Nasdaq: HLTH) will release its second quarter 2023 financial results on August 9, 2023. The company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results and recent highlights. Participants can access the live call via telephone or the company's website. A replay of the webinar will be available on the website after the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.43%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.86%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.17%
Tags
conferences
Cue Health Inc.

Nasdaq:HLTH

HLTH Rankings

HLTH Stock Data

6.90M
159.09M
11.57%
52.81%
0.49%
Health Information Services
Laboratory Analytical Instruments
Link
United States
SAN DIEGO